According to the latest report published by Data Bridge Market Research, the Noonan Syndrome Market
CAGR Value
The global Noonan syndrome market size was valued at USD 861.98 million in 2...
Posted by Surbhi on June 29 2026 at 05:04 PM
public
MEK inhibitor breakthroughs in Noonan syndrome — the targeted MAPK pathway therapies demonstrating cardiac function improvement in children with severe hypertrophic cardiomyopathy, alongside Novo...
